Gf Fund Management Co. Ltd. Nuvalent, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Nuvalent, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 1,680 shares of NUVL stock, worth $126,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,680
Previous 1,378
21.92%
Holding current value
$126,000
Previous $108 Million
10.45%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NUVL
# of Institutions
216Shares Held
60.9MCall Options Held
319KPut Options Held
211K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.35 Billion32.3% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$395 Million19.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.44MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$227 Million0.01% of portfolio
-
Commodore Capital LP New York, NY1.86MShares$139 Million12.88% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $3.22B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...